Cargando…
Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
PURPOSE: The prevalence of diabetes and diabetes-related complications, including diabetic macular edema (DME), is increasing in Asia and worldwide. METHODS: VIVID-East was a 12-month, double-masked, randomized, active-controlled, Phase 3 trial (NCT01783886) enrolling adult patients (aged ≥18 years)...
Autores principales: | Chen, You-Xin, Li, Xiao-Xin, Yoon, Young Hee, Sun, Xiaodong, Astakhov, Yury, Xu, Gezhi, Wang, Hui, Ren, Xiaowei, Asmus, Friedrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069586/ https://www.ncbi.nlm.nih.gov/pubmed/32210527 http://dx.doi.org/10.2147/OPTH.S235267 |
Ejemplares similares
-
Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept
por: Mansour, Ahmad M, et al.
Publicado: (2019) -
Coats' Disease-Related Macular Edema Treated with Combined Aflibercept and Laser Photocoagulation
por: Shieh, Wen-Shi, et al.
Publicado: (2017) -
Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data
por: Ziemssen, Focke, et al.
Publicado: (2016) -
Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
por: Klein, Kendra A., et al.
Publicado: (2017) -
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)